Skip to main content

Apply to the Career Development Program (CDP)

Supporting the future leaders in blood cancer research and treatment

CDP is currently closed.


 

The Leukemia & Lymphoma Society supports talented blood cancer researchers in the early phase of their careers through the Career Development Program. CDP continues to provide a pool of dedicated researchers to advance the understanding and diagnosis of blood cancer, as well as the development of treatment and prevention options that will ultimately lead to a higher quality of life for blood cancer patients

Click here to see our active CDP portfolio.


2023-2024 Timeline and Key Dates*

Phase Date
Eligibility Phase deadline October 27, 2023, 3:00 PM (ET)
Letter of Intent Phase deadline November 15, 2023, 3:00 PM (ET)
Reference letters deadline December 1, 2023, 3:00 PM (ET)
Full Application Phase deadline December 1, 2023, 3:00 PM (ET)
Award Start Date July 1, 2024

*Please refer to the program-specific Guidelines & Instructions document available for download below for the detailed timelines

Award Categories

Scroll down to see all CDP subcategories or click each category to jump to the appropriate subprogram section:

Basic/Translational:

Clinical:

 

CDP provides salary support to assist the awardee pursuing their research program. The application should reflect the research program of the applicant, particularly in the Scholar and Scholar in Clinical Research subcategories. See the Guidelines & Instructions for more information. Please refer to the Eligibility Outline in the Guidelines & Instructions for each subcategory to determine which subcategory is most appropriate for your application.

 


Download the LLS Policies and Procedures applicable to all grant programs here:


Fellow

The Fellow program supports high quality postdocs who have clearly demonstrated productivity and critical thinking in their graduate studies as well as in their short time as a postdoc. You must have less than 3 years of postdoctoral research training by the award start date. This award encourages you to embark on an academic career involving basic or translational research in hematologic malignancies and/or relevant premalignant conditions under a research mentor’s direction. Your research must be directly relevant to hematologic malignancies and/or relevant pre-malignant conditions. In addition, your Sponsor (mentor) must have the appropriate experience to mentor you as you engage in research of direct relevance to blood cancer.

This award is for 3 years and the maximum award per year is $70,000. The minimum stipend/salary going directly to the awardee is $70,000/year. Fellow awardees may also be eligible for an additional childcare stipend of up to $3,600 per year.

*Please find all program documents available for download below:


Special Fellow

The Special Fellow award supports postdocs and instructors having between 3 and 5 years of postdoctoral research training by the award start date, who have clearly demonstrated success in their current postdoctoral/instructor position, and who need an additional 2-3 years of training to be competitive for an independent position. This award provides you with the opportunity to continue building a research program that will make you competitive for an independent position by the end of the award funding period.

You must be in a mentored research position, continuing a research program of direct relevance to hematologic malignancies and/or relevant pre-malignant conditions. In addition, your Sponsor (mentor) must have the appropriate experience to mentor you as you engage in blood cancer-relevant research.

This award is for 2 or 3 years, depending on eligibility, and the maximum award per year is $75,000. The minimum stipend/salary going directly to the awardee is $70,000/year. Special Fellow awardees may also be eligible for an additional childcare stipend of up to $3,600 per year.

*Please find all program documents available for download below:


Scholar

The Scholar award supports rising stars in the blood cancer research field. You must be a highly qualified investigator who has shown a capacity for independent, sustained, original investigation in the field of hematologic malignancies and/or relevant pre-malignant conditions. You should hold an independent, tenure-track faculty-level position and must have substantial research support awarded from a national agency. Scholar applicants are primarily basic and translational researchers; those who are primarily clinical researchers should consider the Scholar in Clinical Research subcategory.

This award is for 5 years and the maximum award per year is $120,000.

*Please find all Program documents available for download below:


Scholar in Clinical Research

You must be a highly qualified investigator who holds an independent faculty-level appointment and is conducting independent clinical research, often involving early-stage clinical trials, that will advance the prevention, diagnosis, or treatment of hematologic malignancies and/or relevant pre-malignant conditions. The research should be related to your clinical activities and must directly involve patients. Investigators who are primarily laboratory-based, and/or who are working on primarily blood cancer model systems rather than blood cancer patients are not eligible for the Scholar in Clinical Research Award and should consider applying for the Scholar Award instead.

This award is for 5 years and the maximum award per year is $125,000.

*Please find all program documents available for download below:

 


How to apply

  • Please refer to the appropriate Guidelines & Instructions document above
  • Is this your first time applying for an LLS Research grant? You can get started by requesting a new account in the LLS Research Portal by clicking here

 

More Questions?

  • Please refer to the downloadable Guidelines & Instructions document above for answers and for contact information.